Search

Cr, Fe, Ce and W doped MoVTeNbO M2 phase catalysts were synthesized and used in the selective oxidation of propylene to acrylic acid (AA). Results show that the introduction of Cr, Fe, Ce and W substantially affects the physicochemical properties and catalytic performance of MoVTeNbO-based catalysts. Un-doped catalyst consists of M2 phase and TeO2, while Cr, Fe, Ce and W-doped catalysts are mainly composed of M2 and MoO3. It is indicated that doping of Cr, Fe, Ce and W can restrain the formation of TeO2, but favour the formation of MoO3. Un-doped, Cr and W-doped catalysts display irregular-shaped particles morphology, while Fe and Ce-doped catalysts display nanosheets morphology. In addition, the valence of superficial elements of catalysts changed greatly with the doping elements. For catalytic performance, in addition to Cr, the propylene conversion of the catalyst decreases obviously with doping of other elements, probably due to the drastically reduced specific surface area with doping of Fe, Ce and W. The existence of Cr and Ce can increase the selectivity to AA at all test temperatures (360–440 ℃), while Fe and W-doped catalysts only show higher selectivity than the un-doped one at high temperature of 420 and 440 ℃. It is illustrated that the catalysts with redox ability at relatively low temperature is more favorable for the selectivity to AA. Among them, Cr-doped catalyst shows the highest selectivity (85.3%) and yield (63.5%) of AA at test temperature of 380 ℃, which are 15.3 and 7.5% higher than that of un-doped catalyst, respectively. The M2 phase MoVTeNbO catalysts doped with Cr, Fe, Ce and W have been synthesized. It is demonstrated that the addition of Cr improves the stability of Te4+, and Cr-doped M2 phase shows excellent catalytic performance in the selective oxidation of propylene to acrylic acid.

Background: Long noncoding RNAs (lncRNAs) have emerged as gene regulators in various cancers, including hepatocellular carcinoma (HCC). However, the biological roles and mechanisms of many lncRNAs in HCC tumorigenesis remain unknown. Aim: To identify novel lncRNAs associated with proliferation and metastasis in HCC. Methods: Expression profiles of lncRNAs were analyzed in HCC using two GSE datasets (GSE94660 and GSE104310). Functional studies were performed, including cell proliferation, colony formation, wound healing, and Transwell assays. Fluorescence in-situ hybridization (FISH), tandem mass tag (TMT) analyses, parallel reaction monitoring (PRM), and rescue assays were performed to evaluate the mechanisms underlying the effects of RP4-694A7.2. Results: RP4-694A7.2 levels were higher in HCC tissues than in normal liver tissues in published GSE datasets and were elevated in HCC cell lines. Cell function assays revealed that RP4-694A7.2 promotes cell proliferation, invasion, and migration. Furthermore, RP4-694A7.2 was primarily found to be located in the cytoplasm by FISH assay. Then, TMT assay was performed to predict proteins associated with RP4-694A7.2, and 28 cytoplastic proteins were identified by PRM. Finally, phosphoserine aminotransferase 1 (PSAT1) was found to be regulated by RP4-694A7.2 to modulate growth and metastasis in HCC cells using a rescue assay. Conclusions: These results suggested that RP4-694A7.2 promotes HCC cell proliferation and metastasis via PSAT1, providing a candidate therapeutic target for further research.

A series of Ce-doped MoVOx composite metal oxide catalysts were prepared by the rotary evaporation method. The effects of Ce doping ratio on the crystal phase composition, morphology and surface properties of the catalysts were investigated. The results show that the crystal phase composition of samples with different Ce doping content is also obviously different. When the doping amount is small, V0.95Mo0.97O5 is the main crystal phase, while MoO3 is dominant when the doping amount is large. The Ce-doped catalyst showed obvious rod-shaped morphology and its average single point pore diameter and the number of acidic sites increased. Compared to the un-doped MoVOx, the pore size of the sample synthesized at a Mo/Ce atomic ratio of 10/1 exhibited an increase of 41.11 nm. In addition, the effect of Ce doping on the catalytic performance of MoVOx was investigated with the selective oxidation of benzyl alcohol as a probe reaction. After doping, the MoVOx catalyst showed improved benzyl alcohol conversion and selectivity to benzaldehyde. At a Mo/Ce atomic ratio of 10/1, the conversion rate of benzyl alcohol reaches 83.26%, which is 64.56% higher than that without doping, and the highest product yield can reach 76.47%.

BACKGROUND The exact regulation network of programmed death 1 (PD-1), programmed death ligand 1 (PD-L1), and programmed death ligand 2 (PD-L2) signaling in immune escape is largely unknown. We aimed to describe the gene expression profiles related to PD-1 as well as its ligands PD-L1 and PD-L2, thus deciphering their possible biological processes in hepatocellular carcinoma (HCC). AIM To find the possible mechanism of function of PD-1, PD-L1, and PD-L2 in HCC. METHODS Based on the expression data of HCC from The Cancer Genome Atlas, the PD-1/PD-L1/PD-L2 related genes were screened by weighted correlation network analysis method and the biological processes of certain genes were enriched. Relation of PD1/PD-L1/PD-L2 with immune infiltration and checkpoints was investigated by co-expression analysis. The roles of PD-1/PD-L1/PD-L2 in determination of clinical outcome were also analyzed. RESULTS Mutations of calcium voltage-gated channel subunit alpha1 E, catenin beta 1, ryanodine receptor 2, tumor suppressor protein p53, and Titin altered PD-1/PD-L1/PD-L2 expression profiles in HCC. PD-1, PD-L1, and PD-L2 related genes were mainly enriched in biological procedures of T cell activation, cell adhesion, and other important lymphocyte effects. In addition, PD-1/PD-L1/PD-L2 was related with immune infiltration of CD8 T cells, cytotoxic lymphocytes, fibroblasts, and myeloid dendritic cells. Immune checkpoints of CTLA4, CD27, CD80, CD86, and CD28 were significantly related to the PD-1/PD-L1/PD-L2 axis. Clinically, PD-1 and PD-L2 expression was correlated with recurrence (P = 0.005 for both), but there was no significant correlation between their expression and HCC patient survival. CONCLUSION Mutations of key genes influence PD-1, PD-L1, and PD-L2 expression. PD-1, PD-L1, and PD-L2 related genes participate in T cell activation, cell adhesion, and other important lymphocyte effects. The finding that PD-1/PD-L1/PD-L2 is related to immune infiltration and other immune checkpoints would expand our understanding of promising anti-PD-1 immunotherapy.

Liver stiffness measurement (LSM) frequently overestimates the severity of liver fibrosis because of steatosis. However, the impact of the controlled attenuation parameter (CAP) on liver stiffness cutoff values remains unknown; CAP was used to quantify and diagnose the severity of hepatic steatosis. The study was conducted to determine the effect of CAP on liver stiffness cutoff values in chronic hepatitis B (CHB) patients. A retrospective cross-sectional study was performed in liver biopsy-proven CHB patients. The median LSM (kPa) in the elevated CAP group was higher than that in the normal CAP group at the same fibrosis stage. For S2-4, the area under the receiver operating characteristic (AUROC) curve of LSM was 0.78 and 0.72 in the normal and elevated CAP groups, respectively. When a cutoff value of 8.9 kPa was used, the diagnostic accuracy was 77.82% and 63.41% in the normal and elevated CAP groups, respectively. Compared with the alanine transaminase (ALT)-based LSM algorithm, the CAP-based LSM algorithm had a similar correct diagnosis rate (33.64% vs. 33.94%, respectively) but a lower misdiagnosis rate (16.97% vs. 20.30%, respectively). The new CAP-based LSM diagnostic algorithm will improve the diagnostic accuracy of liver fibrosis in CHB patients.

A fast and simple sub-/supercritical water synthesis method is presented in this work in which MoVTeNbOx-mixed metal oxides with various phase compositions and morphologies could be synthesized without post-heat treatment. It was demonstrated that the system temperature for synthesis had a significant influence on the physico-chemical properties of MoVTeNbOx. Higher temperatures were beneficial for the formation of a mixed crystalline phase containing TeVO4, Te3Mo2V2O17, Mo4O11 and TeO2, which are very different from the crystalline phases of conventional Mo–V–Te–Nb-mixed metal oxides. While at lower temperatures, Mo4O11 was replaced by Te. At high temperature, the as-prepared samples presented distinct nanoflake morphologies with an average size of 10–60 nm in width and exhibited excellent catalytic performances in the selective oxidation of propylene to acrylic acid. It is illustrated that the large specific surface area, presence of Mo4O11 and superficial Mo6+ and Te4+ ions are responsible for the high propylene conversion, while suitable acidic sites and superficial Nb5+ ions improved the selectivity to acrylic acid.

Alanine aminotransferase (ALT) is a common clinical indicator of liver inflammation. The current Chinese guidelines for the management of chronic hepatitis B (CHB) recommend antiviral treatment for patients with detectable hepatitis B virus (HBV) DNA and persistent ALT levels (ALTs) exceeding the upper limit of normal. However, it has been recently reported that patients with chronic HBV infection, especially HBeAg-negative patients with persistently normal ALTs, may have liver biopsy findings of significant inflammation and fibrosis. For HBeAg-negative patients with chronic HBV infection and normal ALTs, many controversial questions have been asked. To treat or not? When to initiate the treatment? Which drug is appropriate? In this review, we summarize the available data on the management of HBeAg-negative patients with chronic HBV infection and normal ALTs with the aim of improving the current clinical management.

A series of MoVTeNbOx-mixed metal oxides were synthesized by high-pressure hydrothermal method. The effects of temperature and time during the preparation process on the structure and catalytic performance of MoVTeNbOx were investigated. It was demonstrated that high content of M1 phase (94.5%) MoVTeNbOx with typical needle-shape morphology and high surface abundance of V5+ (68.9%) could be fabricated by high-pressure hydrothermal method in a short time (30 min to 60 min) without hydrogen peroxide post-treatment. The catalytic results of propane selective oxidation showed that the MoVTeNbOx sample synthesized at 200 °C for 30 min possessed the highest surface V5+ abundance and largest proportion of terminating (001) plane, displaying the highest selectivity (74.1%) for acrylic acid. Moreover, the prepared MoVTeNbOx showed excellent stability in high temperature continuous reaction.

The immune checkpoint of PD-1/PD-L1/PD-L2 has been suggested to be an effective target of immunotherapy in a variety types of cancer. However, the potential regulating network of PD-1/PD-L1/PD-L2 signaling in immune escape still remains unclear in hepatocellular carcinoma (HCC). Based on transcriptional data of hepatocellular carcinoma from TCGA. The role of PD-1/PD-L1/PD-L2 in determination of clinical were analysed. The relationship between mutation and PD gene were analysed. PD-1/PD-L1/PD-L2 correlated genes were screened by WGCNA analysis and the biological process of certain genes were enriched. Relation of PD1/PD-L1/PD-L2 with immune infiltration and checkpoints were investigated by co-expression analysis. Clinically, PD-1 and PD-L2 expressions were correlated with recurrence (both P= 0.005) but no significant correlation was found between PD-1/PD-L1/PD-L2 and HCC survival. Mutations of CACNA1E, CTNNB1, RYR2, TP53 and TTN altered PD-1/PD-L1/PD-L2 expression profiles in HCC. PD-1/PD-L1/PD-L2 correlated genes mainly enriched in biological process of T cell activation and cell-cell adhesion. In addition, PD-1/PD-L1/PD-L2 was related with immune infiltration of CD8 T cells, and cytotoxic lymphocytes. Immune checkpoints of CTLA4, CD27, CD80, CD86, CD28 significantly correlated with PD-1/PD-L1/PD-L2 axis. Funding Statement: This study is supported by grants from the National Science and Technology Major Project (2017ZX10201201;2017ZX10202202);Liaoning Province Natural Science Foundation [20180550096] Declaration of Interests: All of the authors declare that there is no conflict of interest. Ethics Approval Statement: Not required.